Cyclooxygenase (COX)-2 as a potent molecular target for prevention and therapy of oral cancer
Cyclooxygenase (COX)-2 is one of two isoforms of COX that is the rate-limiting enzyme in the production of prostaglandin from arachidonic acid. It is induced by stimuli such as mitogens, cytokines, growth factors and tumor promoters, and has been elucidated to be up-regulated not only at the sites o...
Saved in:
Main Author: | Masahiro Urade (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2008-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
by: Harris RE, et al.
Published: (2012) -
Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
by: Wei Qi, et al.
Published: (2012) -
Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities
by: Noor ul Amin Mohsin, et al.
Published: (2022) -
Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature
by: Alessandra Pannunzio, et al.
Published: (2018) -
Design, synthesis, molecular modeling and biological evaluation of novel diaryl heterocyclic analogs as potential selective cyclooxygenase-2 (COX-2) inhibitors
by: Deema A. Al-Turki, et al.
Published: (2017)